Flow cytometric analysis of p53 expression during the cell cycle

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Mutant p53 is prevalent in many carcinomas and its role in cell growth inhibition is unclear.
• Understanding the function of mutant p53 is crucial for cancer research and therapeutic development.

Purpose of the Study:

• To investigate the relationship between mutant p53 expression and the cell cycle in A431 carcinoma cells.
• To determine if mutant p53 expression correlates with cell proliferation markers.

Main Methods:

• Two-parameter flow cytometry (FCM) was used to analyze p53 expression and DNA content during the cell cycle.
• Fluorescence in situ hybridization (FISH) was employed to assess p53 gene copy number and chromosome ploidy.
• Cells were treated with serum deprivation, hydroxyurea, cycloheximide, and Triton X-100 to modulate p53 expression.

Main Results:

• A431 cells consistently expressed high levels of p53 throughout the cell cycle.
• p53 expression decreased under serum deprivation and hydroxyurea treatment, but the cell cycle distribution pattern remained unchanged.
• Cycloheximide treatment transiently reduced p53 levels, while Triton X-100 increased p53 immunoreactivity.
• Mutant p53 expression did not correlate with proliferative markers like PCNA, Ki-67, or DNA polymerase-alpha.

Conclusions:

• Mutant p53 expression in A431 cells is independent of the cell cycle.
• Mutant p53 does not function as a proliferative marker in this carcinoma cell line.
• These findings suggest a distinct role for mutant p53 in carcinoma pathogenesis, separate from direct cell cycle regulation.